Meta-Analysis of the Prognostic Significance of Carotid Artery Stenosis in Patients Who Underwent Transcatheter Aortic Valve Implantation

Stroke is a known complication of both transcatheter aortic valve implantation (TAVI) and carotid artery stenosis (CAS). Whether CAS is a predictor of worse prognosis after TAVI is unclear. We performed a meta-analysis to assess the impact of CAS on the incidence of neurovascular complications and mortality after TAVI. We searched PubMed/MEDLINE and EMBASE databases from inception to January 2023. CAS was defined by ≥50% stenosis of at least 1 carotid artery. Studies comparing CAS versus non-CAS TAVI populations were included. Patients’ baseline characteristics and 30-day clinical outcomes were extracted. End points included the 30-day incidence of neurovascular complications (stroke or transient ischemic attack) and 30-day all-cause mortality. We identified six studies, totaling 6,763 patients in the CAS group and 23,861 patients in the non-CAS group. Patients with CAS had a higher prevalence of hypertension, diabetes mellitus, dyslipidemia, previous myocardial infarction, coronary artery bypass graft, peripheral artery disease, previous neurovascular disease, and chronic kidney disease. There was no significant difference in the rates of 30-day neurovascular complications between CAS and non-CAS groups (relative risk 1.23, 95% confidence interval 0.63 to 2.40, p = 0.54). CAS was associated with a higher risk of 30-day all-cause mortality (relative risk 1.28, 95% confidence interval 1.12 to 1.47, p <0.001), not found in a sensitivity analysis. In conclusion, patients with CAS presented with a significantly higher co-morbidity burden. CAS was not associated with an increased risk of 30-day neurovascular complications. 30-day mortality was higher in the CAS group but that may be a surrogate of the heavy co-morbidity burden of patients with CAS. Stroke is a known complication of both transcatheter aortic valve implantation (TAVI) and carotid artery stenosis (CAS). Whether CAS is a predictor of worse prognosis after TAVI is unclear. We performed a meta-analysis to assess the impact of CAS on the incidence of neurovascular complications and mortality after TAVI. We searched PubMed/MEDLINE and EMBASE databases from inception to January 2023. CAS was defined by ≥50% stenosis of at least 1 carotid artery. Studies comparing CAS versus non-CAS TAVI populations were included. Patients’ baseline characteristics and 30-day clinical outcomes were extracted. End points included the 30-day incidence of neurovascular complications (stroke or transient ischemic attack) and 30-day all-cause mortality. We identified six studies, totaling 6,763 patients in the CAS group and 23,861 patients in the non-CAS group. Patients with CAS had a higher prevalence of hypertension, diabetes mellitus, dyslipidemia, previous myocardial infarction, coronary artery bypass graft, peripheral artery disease, previous neurovascular disease, and chronic kidney disease. There was no significant difference in the rates of 30-day neurovascular complications between CAS and non-CAS groups (relative risk 1.23, 95% confidence interval 0.63 to 2.40, p = 0.54). CAS was associated with a higher risk of 30-day all-cause mortality (relative risk 1.28, 95% confidence interval 1.12 to 1.47, p <0.001), not found in a sensitivity analysis. In conclusion, patients with CAS presented with a significantly higher co-morbidity burden. CAS was not associated with an increased risk of 30-day neurovascular complications. 30-day mortality was higher in the CAS group but that may be a surrogate of the heavy co-morbidity burden of patients with CAS. Transcatheter aortic valve implantation (TAVI) is currently the first-line procedure for the treatment of symptomatic severe aortic stenosis, in patients aged 75 years or more, or those younger and at high surgical risk.1Vahanian A Beyersdorf F Praz F Milojevic M Baldus S Bauersachs J Capodanno D Conradi L De Bonis M De Paulis R Delgado V Freemantle N Gilard M Haugaa KH Jeppsson A Jüni P Pierard L Prendergast BD Sádaba JR Tribouilloy C Wojakowski W ESC/EACTS Scientific Document Group2021 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J. 2022; 43: 561-632Crossref PubMed Scopus (1180) Google Scholar, 2Otto CM Nishimura RA Bonow RO Carabello BA Erwin 3rd, JP Gentile F Jneid H Krieger EV Mack M McLeod C O'gara PT Rigolin VH Sundt 3rd, TM Thompson A Toly C 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines.Circulation. 2021; 143: e35-e71PubMed Google Scholar, 3Mauri V Abdel-Wahab M Bleiziffer S Veulemans V Sedaghat A Adam M Nickenig G Kelm M Thiele H Baldus S Rudolph TK. Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013–2020.Clin Res Cardiol. 2022; 111: 881-888Crossref PubMed Scopus (7) Google Scholar Cerebrovascular ischemic events (stroke or transient ischemic attack [TIA]) after TAVI have an incidence of around 2% to 4% and are associated with reduced quality of life and increased morbidity and mortality.4Vlastra W Jimenez-Quevedo P Tchétché D Chandrasekhar J de Brito Jr, FS Barbanti M Kornowski R Latib A D'Onofrio A Ribichini F Baan J Tijssen JGP De la Torre Hernandez JM Dumonteil N Sarmento-Leite R Sartori S Rosato S Tarantini G Lunardi M Orvin K Pagnesi M Hernandez-Antolin R Modine T Dangas G Mehran R Piek JJ Delewi R Predictors, incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke.Circ Cardiovasc Interv. 2019; 12e007546Crossref PubMed Scopus (50) Google Scholar, 5Kapadia S Agarwal S Miller DC Webb JG Mack M Ellis S Herrmann HC Pichard AD Tuzcu EM Svensson LG Smith CR Rajeswaran J Ehrlinger J Kodali S Makkar R Thourani VH Blackstone EH Leon MB. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (placement of aortic transcatheter valves).Circ Cardiovasc Interv. 2016; 9e002981Crossref Scopus (121) Google Scholar, 6Tchetche D Farah B Misuraca L Pierri A Vahdat O Lereun C Dumonteil N Modine T Laskar M Eltchaninoff H Himbert D Iung B Teiger E Chevreul K Lievre M Lefevre T Donzeau-Gouge P Gilard M Fajadet J. Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy.JACC Cardiovasc Interv. 2014; 7: 1138-1145Crossref PubMed Scopus (56) Google Scholar, 7Eggebrecht H Schmermund A Voigtländer T Kahlert P Erbel R Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients.EuroIntervention. 2012; 8: 129-138Crossref PubMed Scopus (302) Google Scholar, 8Centers for Disease Control and Prevention (CDC)Prevalence and most common causes of disability Google Scholar, J in the Scholar artery stenosis is associated with an increased risk of complications after coronary artery bypass and valvular A S J D H O P Smith Jr, for the of stroke in patients with stroke and transient ischemic a guideline from the American Heart Stroke 2021; PubMed Scopus Google Scholar, A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google Scholar, JR Hernandez Jr, F DC Disease of of to coronary artery bypass PubMed Scopus Google Scholar, A M N G carotid artery in valvular heart impact of on surgical and 2012; PubMed Scopus Google Scholar, H J. Cerebrovascular events after aortic valve replacement a PubMed Scopus Google Scholar is known impact in patients A Beyersdorf F Praz F Milojevic M Baldus S Bauersachs J Capodanno D Conradi L De Bonis M De Paulis R Delgado V Freemantle N Gilard M Haugaa KH Jeppsson A Jüni P Pierard L Prendergast BD Sádaba JR Tribouilloy C Wojakowski W ESC/EACTS Scientific Document Group2021 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J. 2022; 43: 561-632Crossref PubMed Scopus (1180) Google V M M T JP M De M S C T S L M J M M G M C Scientific Document Guidelines on the and treatment of peripheral in with the for Document of carotid and and the Stroke for the and of of the of and of the for Heart J. PubMed Scopus Google Scholar We performed a with meta-analysis of to the prevalence of CAS in TAVI and the characteristics of patients with CAS and the risk of 30-day neurovascular complications and all-cause mortality to We the of the for of for of Scholar were to the for and D A J for and the J 8: PubMed Scopus Google Scholar was performed databases PubMed/MEDLINE and and EMBASE from inception to January 2023. and were artery aortic valve aortic valve and CAS was defined ≥50% stenosis of at least carotid by in with BA M J S L J artery and of in PubMed Scopus Google Scholar Studies were included the of CAS versus on baseline and 30-day clinical clinical studies, and were was by and and was by or with the of a quality of was by the D comparing to Res 2014; PubMed Scopus Google Scholar outcomes included 30-day incidence of neurovascular complications (stroke or and 30-day mortality were P N Blackstone EH Kodali S Mack Mehran R J P Webb JG S Leon for transcatheter aortic valve the J 2012; PubMed Scopus Google Scholar were not were published after most included in P N T P JJ P Blackstone EH S A Mack Makkar R Mehran R JJ M J Webb JG Leon for aortic valve clinical Heart J. 2021; PubMed Scopus Google Scholar characteristics were for were with or with were presented with characteristics were between groups for and for were not in the were not to a p were and a was and 95% confidence were to the of between CAS and the outcomes of a sensitivity was performed with the of the with the to the of the was to for and was defined the that was to to of to and for of Scholar were the and A of were identified in the In after and were at the for with six included in A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar, peripheral not impact or after transcatheter aortic valve J Google Scholar, JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google Scholar, J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google Scholar, S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar the of with or with an that be included were to for A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google peripheral not impact or after transcatheter aortic valve J Google S F M C M Tarantini G and impact of carotid artery in patients undergoing transcatheter aortic valve 2022; PubMed Scopus Google Scholar, T J O E of transcatheter aortic valve replacement in patients with carotid artery 2019; Google Scholar, C J M stroke risk transcatheter aortic valve 2022; PubMed Scopus Google Scholar, A C B K J RA V M A P Thourani VH Heart and carotid surgical or transcatheter aortic valve PubMed Scopus Google Scholar peripheral not impact or after transcatheter aortic valve J Google Scholar were in A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar, peripheral not impact or after transcatheter aortic valve J Google Scholar, JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar and from a A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar of baseline characteristics between patients with CAS and those was not in A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google Scholar neurovascular complications were defined in the included studies, the P N Blackstone EH Kodali S Mack Mehran R J P Webb JG S Leon for transcatheter aortic valve the J 2012; PubMed Scopus Google Scholar in the by A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google Scholar, in the not the for the of included the incidence of stroke at A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google Scholar included both the incidence of stroke and peripheral not impact or after transcatheter aortic valve J Google S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google Scholar and S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar the of neurovascular in both the was on clinical and a quality were high quality and for in meta-analysis six included a of in the CAS group and 23,861 in the non-CAS group. surgical and transcatheter heart valve are in between patients with CAS and those are in and Patients with CAS were and presented with a significantly higher prevalence of diabetes mellitus, dyslipidemia, previous myocardial and coronary artery bypass graft, coronary artery disease, peripheral artery disease, previous neurovascular disease, chronic kidney higher co-morbidity burden in patients with CAS was by a higher surgical risk p of p CAS non-CAS or was significantly in the non-CAS group p <0.001), was no significant difference chronic p = transfemoral was in the non-CAS group p that patients in the CAS group were previous neurovascular in the six J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google Scholar performed carotid A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar the of was = treatment in A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google = by carotid in S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar that the 30-day incidence of neurovascular complications was patients with 95% to and previous 95% to neurovascular were in six A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar, peripheral not impact or after transcatheter aortic valve J Google Scholar, JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google Scholar, J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google Scholar, S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar incidence of 30-day neurovascular complications in patients TAVI was There was no significant difference in the incidence of neurovascular complications between was 1.23, 95% 0.63 to 2.40, p = = were found in the sensitivity after of the with the 95% to p = = A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google peripheral not impact or after transcatheter aortic valve J Google Scholar, JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google Scholar, J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google Scholar, S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar 30-day all-cause were in six A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar, peripheral not impact or after transcatheter aortic valve J Google Scholar, JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google Scholar, J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google Scholar, S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar 30-day mortality in patients TAVI was risk of 30-day all-cause mortality was higher in the CAS with the non-CAS group 1.28, 95% 1.12 to 1.47, p = was not found in the sensitivity after of the with the 95% to p = = A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google peripheral not impact or after transcatheter aortic valve J Google Scholar, JJ of between carotid and artery and stroke after transcatheter aortic valve J Cardiol. 2016; PubMed Scopus Google Scholar, J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google Scholar, S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar of the meta-analysis are in and meta-analysis is the to the prevalence of CAS in TAVI populations and the between CAS and clinical after TAVI. be of patients TAVI presented with patients with CAS presented with a significantly higher co-morbidity was no significant difference in the risk of 30-day neurovascular complications between the CAS and non-CAS was a higher risk of 30-day all-cause mortality associated with the of CAS but was not in the sensitivity analysis. prevalence of CAS in patients TAVI in meta-analysis was higher was in the in M JP B M M E of carotid artery stenosis in the an PubMed Scopus Google Scholar a may be by the that of the of aortic stenosis is to of aortic stenosis and CAS may a an of chronic and G G R K Association between carotid and aortic 2012; PubMed Scopus Google Scholar In aortic to be a of F E M C M F Association between carotid and coronary artery in patients with aortic valve an PubMed Scopus Google Scholar the incidence of stroke or at in meta-analysis in the of in the registry = of patients a stroke at after W Jimenez-Quevedo P Tchétché D Chandrasekhar J de Brito Jr, FS Barbanti M Kornowski R Latib A D'Onofrio A Ribichini F Baan J Tijssen JGP De la Torre Hernandez JM Dumonteil N Sarmento-Leite R Sartori S Rosato S Tarantini G Lunardi M Orvin K Pagnesi M Hernandez-Antolin R Modine T Dangas G Mehran R Piek JJ Delewi R Predictors, incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke.Circ Cardiovasc Interv. 2019; 12e007546Crossref PubMed Scopus (50) Google Scholar the of Transcatheter trial = a 30-day of stroke or of S Agarwal S Miller DC Webb JG Mack M Ellis S Herrmann HC Pichard AD Tuzcu EM Svensson LG Smith CR Rajeswaran J Ehrlinger J Kodali S Makkar R Thourani VH Blackstone EH Leon MB. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (placement of aortic transcatheter valves).Circ Cardiovasc Interv. 2016; 9e002981Crossref Scopus (121) Google Scholar have to incidence of neurovascular events after TAVI. is to be to the and of and aortic by the of and and implantation of the S M K B D N A G A clinical outcomes of transcatheter aortic valve replacement in patients with carotid artery from the J Heart Google Scholar, JG P E A Herrmann HC transfemoral and transcatheter aortic valve PubMed Scopus Google Scholar, P F P K B D L E M P D M T G Erbel R transcatheter aortic valve a 2012; PubMed Scopus Google Scholar, DC Blackstone EH Mack Svensson LG Kodali S Rajeswaran J Tuzcu EM Webb JG Leon Smith CR PARTNER and Stroke and versus surgical aortic valve risk factors, and of events in the PARTNER Cardiovasc 2012; Scopus Google Scholar, R N F D A J R Thompson C Webb A for events after transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar have by in to of patients after P M M F M D M S Erbel R and after transfemoral aortic valve a PubMed Scopus Google M RA in or Cardiol. 2019; PubMed Scopus Google Scholar in the the of a the 30-day stroke was in the group versus in the Kodali S Makkar R Mehran R R H R S Thourani VH T N F A S T M JM L A Svensson L C A Leon A transcatheter aortic valve Cardiol. PubMed Scopus Google Scholar from the Transcatheter included and a meta-analysis published that the of not significantly the incidence of neurovascular events in patients Makkar R D G S T and outcomes of transcatheter aortic valve from the Transcatheter 2021; 143: PubMed Scopus Google of of transcatheter aortic valve J Cardiol. 2021; PubMed Scopus Google Scholar published clinical trial that the of a not significantly the incidence of patients Makkar R Leon M Abdel-Wahab M T S W S L J R L J Kodali S A Thourani VH K S R A transcatheter J 2022; PubMed Scopus Google Scholar of that may be at in the of stroke after TAVI. In may be the transient and peripheral by the is to to and of the B G P M C E L P Dumonteil N M J T TAVI the valve in transcatheter aortic valve Cardiovasc Interv. 2019; PubMed Scopus Google Scholar may be with or of the aortic valve is Patients with CAS at baseline may be to after to the of kidney and after H D P O M M E M and of artery stenosis in patients undergoing transcatheter aortic valve Cardiovasc 2022; W C Transcatheter aortic valve a 2016; PubMed Google Scholar a the carotid A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar meta-analysis no significant between the 30-day incidence of neurovascular events and CAS. were by S F M C M Tarantini G and impact of carotid artery in patients undergoing transcatheter aortic valve 2022; PubMed Scopus Google Scholar T J O E of transcatheter aortic valve replacement in patients with carotid artery 2019; Google Scholar C J M stroke risk transcatheter aortic valve 2022; PubMed Scopus Google Scholar A C B K J RA V M A P Thourani VH Heart and carotid surgical or transcatheter aortic valve PubMed Scopus Google Scholar and Thourani VH JJ Mack JM J S S and of a risk for stroke after transcatheter aortic valve a report from the of College of Transcatheter 2019; PubMed Scopus Google Scholar were from meta-analysis of are in with and that of CAS TAVI is V M M T JP M De M S C T S L M J M M G M C Scientific Document Guidelines on the and treatment of peripheral in with the for Document of carotid and and the Stroke for the and of of the of and of the for Heart J. PubMed Scopus Google Scholar higher risk of all-cause mortality at was not found in the sensitivity after the of the by A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar is to that performed a the risk of 30-day mortality for the of patients and found no significant between CAS and 30-day mortality 95% to 1.28, p = not be in included and the that CAS may be a surrogate of the heavy co-morbidity burden of patients with with patients by of the baseline characteristics of We not to the of CAS the to were from the cohort included in meta-analysis that was no between CAS and 30-day A Thourani VH Mack RA Stroke and outcomes in patients with carotid undergoing transcatheter aortic valve Cardiovasc Interv. PubMed Scopus Google Scholar be S F M C M Tarantini G and impact of carotid artery in patients undergoing transcatheter aortic valve 2022; PubMed Scopus Google S R Mehta A J S V L artery and stroke risk after transcatheter aortic valve PubMed Scopus Google Scholar previous that patients with severe carotid have M T M B J severe carotid artery stenosis or and PubMed Scopus Google Scholar may at risk of neurovascular complications after stroke and S A O M E S P O C P P C P outcomes in with carotid artery stenosis in patients undergoing transcatheter aortic valve Cardiol. Google Scholar found a significant between carotid stenosis and the risk of stroke at S R Mehta A J S V L artery and stroke risk after transcatheter aortic valve PubMed Scopus Google Scholar found from a CAS a was not associated with an increased risk of was a significant between CAS and after TAVI 95% to carotid may be in the of severe CAS is patients with CAS were and populations the not in a of of a carotid the a of patients with CAS. to patients the most from for CAS is meta-analysis included and is by and of was the of neurovascular not and and have the incidence of neurovascular A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google J D A S G A carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve J Cardiol. PubMed Scopus Google S M K B D N A G A clinical outcomes of transcatheter aortic valve replacement in patients with carotid artery from the J Heart Google Scholar in outcomes were not defined to the A E S A and of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve Cardiovasc Interv. 2014; PubMed Scopus Google Scholar In conclusion, the prevalence of CAS is high patients TAVI. that CAS a was not a predictor of neurovascular complications at mortality was higher in the CAS group but that may be a surrogate of the heavy co-morbidity burden of patients with CAS. are the of of CAS in patients TAVI and the of CAS on neurovascular complications. have no of to with with with with with